#cariprazine
LightNews LightNews
ririsu.bsky.social
i hate being insane and unwell from stress, fear, and being unmedicated. 4 days ago was the last day i had cariprazine and i actually woke up not completely exhausted that day and got a lot done. then every day since without it ive just gotten increasingly irritable, despairing, sluggish, useless...
September 8, 2026 at 10:03 PM
psychopharm.bsky.social
What do we know about #cariprazine during #breastfeeding? Analysis of milk samples from 5 lactating women found low infant exposure, though reports of infant lethargy and concerns about metabolite accumulation warrant further study.

🔗Read more in JCP: www.ovid.com/jnls/psychop...
September 4, 2026 at 6:35 PM
cryoempapers.bsky.social
The structure of the dopamine D3 receptor bound to cariprazine reveals principles for partial agonists with designed pharmacology pubmed.ncbi.nlm.nih.gov/42664351/ #cryoem
August 29, 2026 at 5:47 PM
ririsu.bsky.social
I think I'm doing better mentally after taking my cariprazine every day instead of every other day, as long as I take it around 11pm

mostly it just fucking sucks that I'll be paying ~$1800 a year to be consistently less insane. $900 was already painful enough lmfao. I hate medication manufacturers
August 13, 2026 at 8:20 PM
ijnp.bsky.social
It highlighs the potential of EEG biomarkers to support personalized treatment strategies in psychiatry.

Read the study: doi.org/10.1093/ijnp...

#Psychiatry #Neuropsychiatry #EEG #Biomarkers #PrecisionPsychiatry #Schizophrenia #Psychopharmacology #Cariprazine #ClinicalResearch #MentalHealth
High-density EEG study in patients with schizophrenia treated with cariprazine
Highlights Resting-state EEG captured neurophysiological changes during cariprazine treatment.Treatment response was linked to changes in resting-EEG spect
doi.org
August 2, 2026 at 11:22 PM
ijnp.bsky.social
🧠 Can EEG help predict who responds to cariprazine?

A recent study by Bitter et al. found that treatment responders showed increased theta and decreased delta resting-state EEG power. Importantly, baseline gamma activity predicted treatment response with high accuracy..
August 2, 2026 at 11:22 PM
thailandmedical.bsky.social
Brain Cancer Breakthrough as Cariprazine Shows Powerful Effects Against Glioblastoma

www.thailandmedical.news/news/brain-c...
Brain Cancer Breakthrough as Cariprazine Shows Powerful Effects Against Glioblastoma - Thailand Medical News
www.thailandmedical.news
June 14, 2026 at 8:32 AM
index.hu.web.brid.gy
Vállvetve a Richterrel: így változtatta meg egy BME-s vegyészmérnök oktató-kutató milliók életét
A nagy cariprazine-sztori háttere az Indexen.
index.hu
January 9, 2026 at 6:43 PM
ljboyd.bsky.social
I very disappointed @abbvie.bsky.social advertise on Hulu Vraylar(Cariprazine) as their Parent company Disney bent the knee to Potus' FCC chairman Carr demand to do this easy or hard to remove Kimmel from the air. Where does this attack on free speech stop?
September 19, 2025 at 12:27 PM
natasha-tracy.bsky.social
Why does a hospital psych reach for an antipsychotic when the chart says “severe depression”—not psychosis?
• FDA-approved add-ons vs. off-label use
• Risks that rarely get explained on the ward
• How (and when) you can say no
l.natashatracy.com/in-hospital-...
#MentalHealth #Depression #Psychiatry
In-Hospital Antipsychotic Prescribing: Off-Label Uses, FDA-Approved Options & Patient Rights (2025) - Natasha Tracy Bipolar Expert
Why are antipsychotics like quetiapine, aripiprazole, brexpiprazole, and cariprazine used in the hospital—even off-label? Learn current FDA-approved options, real-world risks, and how to demand transp...
l.natashatracy.com
June 19, 2025 at 4:45 PM
abyss.fail
cariprazine most certainly qualifies for one!
February 11, 2025 at 9:27 PM
noise.observer
must... make... cariprazine edit
July 13, 2023 at 1:54 AM
mcnpmexico.bsky.social
⚠️ART. Nuevos datos: Cariprazina como complemento al #tratamiento #antidepresivo para los síntomas de anhedonia ➡️https://www.psychiatrictimes.com/view/new-data-cariprazine-adjunctive-to-antidepressant-therapy-for-anhedonia-symptoms
June 30, 2025 at 6:03 PM
affordablerxor.bsky.social
The #Oregon #PDAB is meeting to review: #Trelegy, #Eliquis, #Xarelto, #Cosentyx, & #Creon on Aug. 20 at 8 am!

If you or someone you know has taken any of these (or any others on their list), they need to hear from you! Send a letter/sign up to speak at bit.ly/or-pdab-comment
The Oregon Prescription Drug Affordability Board (PDAB) is reviewing high-cost drugs that may strain Oregon patients or our health care system. They want to hear your experience with high costs on ANY of the prescription drugs on their review list. Use the website below to share: bit.ly/or-pdab-comment On August 20, the Oregon PDAB will review: Trelegy* (Fluticasone furoate; Umeclidinum bromide; Vilanterol trifenatate) Eliquis* (Apixaban) Xarelto (Rivaroxaban) Cosentyx (Secukinumab) Creon (Pancrelipase [Amylase; Lipase; Protease]) * = No generic currently avaiable PDAB Has Already Reviewed: Vraylar* (Cariprazine HCl ) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy* (Ubrogepant) *=no generic currently available you can still share your story about these drugs until November 19
August 5, 2025 at 6:01 PM
affordablerxor.bsky.social
The Oregon Prescription Drug Affordability Board is reviewing #Ajovy (Generic: #Fremanezumab-vfrm) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience.

Public comment form: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Ajovy? Generic: Fremanezumab-vfrm. Therapy Class: Migraine product. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 11, 2025 at 11:30 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Emgality (Generic: #Galcanezumab-gnlm) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, please consider sharing your experience.

Public comment dfr.oregon.gov/pdab/Pages/p...
#OCAP #HealthPolicy
Do you take or have you taken: Emgality? Generic: Galcanezumab-gnlm. Therapy Class: Migraine product. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 11, 2025 at 4:45 PM
affordablerxor.bsky.social
The Oregon Prescription Drug Affordability Board is reviewing #Entresto (Generic: #Sacubitril , #Valsartan) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience. Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Entresto? Generic: Sacubitril; Valsartan. Therapy Class: Cardiovascular agents – misc. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 10, 2025 at 6:28 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Nurtec (Generic: #Rimegepant/ #RimegepantSulfate) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience. Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Nurtec? Generic: Rimegepant/rimegepant sulfate Therapy Class: Migraine product Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 9, 2025 at 11:10 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Ubrelvy (Generic: Ubrogepant) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, please consider sharing your experience.

Public comment form: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Ubrelvy? Generic: Ubrogepant Therapy Class: Migraine product Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 8, 2025 at 9:10 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Vraylar (Generic: #CariprazineHCl) on July 16 starting at 9 AM.

If you or someone you know takes or has taken this medication, consider sharing your experience.

Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Vraylar? Generic: Cariprazine HCl. Therapy Class: Antipsychotics & Antimaic agents. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The Oregon Prescription Drug Affordability Board (PDAB) is reviewing high-cost drugs that may strain Oregon patients or our health care system. PDAB’s First Review Will Be Of: Vraylar (Cariprazine HCl ) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 7, 2025 at 7:23 PM
affordablerxor.bsky.social
Today is the LAST DAY!
If you take/have taken one of the 27 medications under affordability review, the Oregon Prescription Drug Affordability Board (#PDAB) needs to hear from you!
Survey closes TONIGHT! bit.ly/or-pdab-affordability-2025
See the slides for more details!
#Oregon #RXDrugs #OCAP
Last Day! If you take or have taken one of these medications, fill out PDAB's survey now! Survey closes tonight! Swipe to see the list> The Oregon Prescription Drug Affordability Board is reviewing these RX Drugs for affordability: ❤️ Cardiovascular/Anticoagulants * Eliquis – Apixaban * Xarelto – Rivaroxaban * Entresto – Sacubitril/Valsartan 🧠 Migraine Medications * Ajovy – Fremanezumab * Emgality – Galcanezumab * Nurtec – Rimegepant * Ubrelvy – Ubrogepant 🧴 Dermatologicals * Cosentyx – Secukinumab * Dupixent – Dupilumab * Taltz – Ixekizumab * Tremfya – Guselkumab 💉 Antidiabetics * Ozempic – Semaglutide * Trulicity – Dulaglutide * Rybelsus – Semaglutide * Jardiance – Empagliflozin * Mounjaro – Tirzepatide 🎗 Antineoplastics (Cancer/adjunct therapy) * Ibrance – Palbociclib * Perjeta – Pertuzumab * Verzenio – Abemaciclib 🧠 Neurological + Psychotherapeutics * Ocrevus – Ocrelizumab * Vraylar – Cariprazine * Botox – Onabotulinumtoxina 💥 Analgesics/Anti-inflammatories * Humira – Adalimumab * Rinvoq – Upadacitinib 💨 Antiasthmatics/Respiratory * Trelegy – Fluticasone/Umeclidinium/Vilanterol 🦠 Antivirals * Odefsey – Emtricitabine/Rilpivirine/Tenofovir SURVEY CLOSES TONIGHT If you take/have taken any of these medications please fill out the survey. It will ask about: *out of pocket costs *dosage and frequency *insurance, medicare, or OHP coverage Link: bit.ly/or-pdab-affordability-2025
April 30, 2025 at 4:44 PM
affordablerxor.bsky.social
1 day left!
If you take/have taken one of the 27 medications under affordability review, the Oregon Prescription Drug Affordability Board (#PDAB) needs to hear from you! Survey closes April 30! bit.ly/or-pdab-affordability-2025
See the slides for more details!
#Oregon #RXDrugs #OCAP
1 Day Left! Help lower drug prices—if you take or have taken one of these medications PDAB needs to hear from you by April 30! Swipe to see the list The Oregon Prescription Drug Affordability Board is reviewing these RX Drugs for affordability: ❤️ Cardiovascular/Anticoagulants * Eliquis – Apixaban * Xarelto – Rivaroxaban * Entresto – Sacubitril/Valsartan 🧠 Migraine Medications * Ajovy – Fremanezumab * Emgality – Galcanezumab * Nurtec – Rimegepant * Ubrelvy – Ubrogepant 🧴 Dermatologicals * Cosentyx – Secukinumab * Dupixent – Dupilumab * Taltz – Ixekizumab * Tremfya – Guselkumab 💉 Antidiabetics * Ozempic – Semaglutide * Trulicity – Dulaglutide * Rybelsus – Semaglutide * Jardiance – Empagliflozin * Mounjaro – Tirzepatide 🎗 Antineoplastics (Cancer/adjunct therapy) * Ibrance – Palbociclib * Perjeta – Pertuzumab * Verzenio – Abemaciclib 🧠 Neurological + Psychotherapeutics * Ocrevus – Ocrelizumab * Vraylar – Cariprazine * Botox – Onabotulinumtoxina 💥 Analgesics/Anti-inflammatories * Humira – Adalimumab * Rinvoq – Upadacitinib 💨 Antiasthmatics/Respiratory * Trelegy – Fluticasone/Umeclidinium/Vilanterol 🦠 Antivirals * Odefsey – Emtricitabine/Rilpivirine/Tenofovir If you take/have taken any of these medications please fill out the survey. It will ask about: *out of pocket costs *dosage and frequency *insurance, medicare, or OHP coverage Link: bit.ly/or-pdab-affordability-2025
April 29, 2025 at 5:38 PM
affordablerxor.bsky.social
Only 2 days left!
If you take/have taken one of the 27 medications under affordability review, the Oregon Prescription Drug Affordability Board (#PDAB) needs to hear from you! Survey closes April 30! bit.ly/or-pdab-affordability-2025
See the slides for more details!
#Oregon #RXDrugs #OCAP
2 Days Left to Share Your Story! If you take/have taken one of the 27 medications under review, PDAB needs to hear from you by April 30! Swipe to see the list. The Oregon Prescription Drug Affordability Board is reviewing these RX Drugs for affordability: ❤️ Cardiovascular/Anticoagulants * Eliquis – Apixaban * Xarelto – Rivaroxaban * Entresto – Sacubitril/Valsartan 🧠 Migraine Medications * Ajovy – Fremanezumab * Emgality – Galcanezumab * Nurtec – Rimegepant * Ubrelvy – Ubrogepant 🧴 Dermatologicals * Cosentyx – Secukinumab * Dupixent – Dupilumab * Taltz – Ixekizumab * Tremfya – Guselkumab 💉 Antidiabetics * Ozempic – Semaglutide * Trulicity – Dulaglutide * Rybelsus – Semaglutide * Jardiance – Empagliflozin * Mounjaro – Tirzepatide 🎗 Antineoplastics (Cancer/adjunct therapy) * Ibrance – Palbociclib * Perjeta – Pertuzumab * Verzenio – Abemaciclib 🧠 Neurological + Psychotherapeutics * Ocrevus – Ocrelizumab * Vraylar – Cariprazine * Botox – Onabotulinumtoxina 💥 Analgesics/Anti-inflammatories * Humira – Adalimumab * Rinvoq – Upadacitinib 💨 Antiasthmatics/Respiratory * Trelegy – Fluticasone/Umeclidinium/Vilanterol 🦠 Antivirals * Odefsey – Emtricitabine/Rilpivirine/Tenofovir If you take/have taken any of these medications please fill out the survey. It will ask about: *out of pocket costs *dosage and frequency *insurance, medicare, or OHP coverage Link: bit.ly/or-pdab-affordability-2025
April 28, 2025 at 7:58 PM
affordablerxor.bsky.social
🧵 4/5
🧠 #Neurological + #Psychotherapeutics
Ocrevus – Ocrelizumab
Vraylar – Cariprazine
Botox – Onabotulinumtoxina

💥 Analgesics/Anti-inflammatories
Humira – Adalimumab
Rinvoq – Upadacitinib

#Oregon
April 23, 2025 at 5:46 PM
bibliotecahuvh.bsky.social
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazine scientiasalut.gencat.cat/handle/11351... #ScientiaVH
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazine
scientiasalut.gencat.cat
April 17, 2025 at 3:50 PM